Ricols is a Spain-based consultancy providing scientific and regulatory guidance for biotechnology research, with a particular focus on preclinical development of advanced therapy medicinal products and biologics. Founded and led by Dr. Laura Rico, the company helps researchers and biotechnology organisations prepare projects for the transition from research and development to clinical testing.

Its services include regulatory preclinical planning, project management, assessment of translational potential, gap analysis of existing studies, technical writing, and support with funding applications. Ricols also offers training, guidance on GxP compliance, and networking support. The consultancy works with clients to identify the studies and requirements their projects need, explain how to address them, and provide hands-on support where requested.

Its experience includes advanced therapies such as gene and cell therapies, tissue-engineered products, and biologics. The portfolio describes work on preclinical plans and quality controls for CAR-T therapies, bioengineered corneas, engineered skin, and other innovative treatments. Ricols aims to help clients build scientifically sound, regulatorily aligned development pathways while saving time and resources